A Study to Assess Safety and Efficacy of ASP1941 in Combination With Nateglinide in Type 2 Diabetic Patients
Status:
Completed
Trial end date:
2012-10-19
Target enrollment:
Participant gender:
Summary
This study is to evaluate long-term safety and efficacy after concomitant administration of
ASP1941 and Nateglinide inhibitor in Japanese patients with type 2 diabetes mellitus.